Stocks Hitting 52-Week Highs
October 02, 2014 at 10:16 AM EDT
Esperion Therapeutics (NASDAQ: ESPR) shares reached a new 52-week high of $27.905 after the company announced positive top-line Phase 2b ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.